BACKGROUND The carcinogenesis of colorectal cancer (CRC) involves many different
molecules and multiple pathways, and the specific mechanism has not been elucidated until …

Background Colorectal cancer is an important death‐related disease in the worldwide.
However, specific colon cancer tumor markers currently used for diagnosis and treatment …

Background Colorectal cancer (CRC) is one of the most common malignancies worldwide.
Immunotherapy targeting the programmed death protein 1 (PD-1) and its ligand (PD-L1), is a …

The aim of the present study was to identify key genes in colorectal cancer (CRC) that could
be used to reliably diagnose this disease and to explore the potential underlying …

Colorectal cancer (CRC) is a common gastrointestinal malignancy, and recurrence and
metastasis contribute considerably to its high mortality. It is well known that the epithelial …

Background Gastric cancer is a highly heterogeneous disease, which makes it challenging
to develop effective targeted therapies. Although the potassium voltage‐gated channel …

Aiming to find new tumor markers for colorectal cancer (CRC), we applied proteomic
methodologies to compare the soluble sub-proteome of healthy and tumoral colorectal …

Aim: To explore the expression profile of KCNQ1OT1 and its prognostic value in colon and
rectal adenocarcinoma (COAD and READ) separately. Patients & methods …

Objectives: Potassium Calcium-Activated Channel Subfamily N Member 4 (KCNN4) is a
member of the KCNN family. Studies have revealed that KCNN4 is implicated in various …

Background Colorectal cancer (CRC) is a malignancy of remarkable heterogeneity and
heightened morbidity. Cancer associated fibroblasts (CAFs) are abundant in CRC tissues …